[-] Show simple item record

dc.contributor.authorDresang, Lee T.eng
dc.date.issued2011-12eng
dc.description.abstractThere are no RCTs or other quality evidence to recommend either intramuscular (IM) or intravenous (IV) oxytocin over the other for management of the third stage of labor. Professional bodies recommend both routes of administration equally.eng
dc.identifier.citationEvidence-based practice 14, no. 12 (2011): 12eng
dc.identifier.urihttp://hdl.handle.net/10355/12346eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionEvidence Based Practice, 2011eng
dc.relation.ispartofseriesEvidence-based practice 14, no. 12 (2011)eng
dc.relation.ispartofseriesTopics in maternity care (Evidence-based practice, 2011)eng
dc.subjectuterotonic agenteng
dc.subject.lcshChildbirtheng
dc.titleIntramuscular vs intravenous oxytocin for active management of the third stage of laboreng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record